Could Two Cheap, Generic Drugs Improve Breast Cancer Survival Rates?

Two new studies on two inexpensive, commonly used drugs could mean something major for breast cancer patients. Bisphosphonates and aromatase inhibitors (AIs) could be effective at saving lives, and reducing side effects of the disease. The first study, conducted by the UK Institute of Cancer Research, followed two groups of women. Firstly, postmenopausal women who had previously beat breast cancer. Taking AIs reduced the risk of the cancer returning by a third. The study also followed women who had been recently diagnosed with breast cancer. Over a 10 year period, taking AIs reduced the mortality rate associated with the disease by a significant 15%. The second study, also conducted by the institute, concluded that bisphosphonates reduced the risk of cancer reoccurrence (or of the cancer spreading to other parts of the body) by 17%. The drug also was effective in reducing the associated mortality rate by 18%. "These studies provide really good evidence that both of these inexpensive, generic drugs can help to reduce breast cancer mortality in postmenopausal women," explained Richard Gray, a professor at Oxford University and the lead statistician for both studies. As exciting as these new findings are, the drugs ultimately did little for premenopausal women who were diagnosed. While new hope has been given to the older generation, it will take more research to fully uncover something that works for everyone. What are your thoughts on this new discovery? Source: IFL Science Do you follow us on Instagram? [caption id="attachment_100239" align="alignnone" width="100"]snapchat snapcode code @BodyRockTV[/caption]

Leave a comment

All comments are moderated before being published